Added 3 months ago Drug news

BinaxNOW Influenza A & B Card 2 diagnostic test and reader get 510(k) clearance from FDA - Alere

Alere announced that its Alere Reader, a diagnostic analyzer that can be used in both point-of-care and laboratory settings, has...

Added 5 months ago Drug news

FDA approves marketing application for Xpert Xpress Flu and Xpert Xpress Flu/RSV for influenza-Cepheid

Cepheid announced that it has received clearance from the U.S. Food and Drug Administration (FDA) to market Xpert Xpress Flu...

Added 5 months ago Drug news

Rapivab (peramivir) filed with EMA for influenza in adults 18 years and older- BioCryst Pharma

BioCryst Pharmaceuticals announced that the European Medicines Agency (EMA) has accepted the filing of its Rapivab (peramivir) Marketing Authorization Application...

Safety and immunogenicity of co-administered MF59-adjuvanted 2009 pandemic and plain 2009–10 seasonal influenza vaccines in rheumatoid arthritis patients on biologicals

Rheumatoid arthritis (RA) patients under immunosuppressive therapy are particularly susceptible to infections, mainly of the respiratory tract, thus vaccination may...

Added 3 years ago

A/H5N1 prepandemic influenza vaccine (Vepacel®): a guide to its use.

Vepacel® is a prepandemic influenza vaccine (whole virion, Vero cell-derived, inactivated) containing antigen of H5N1 strain A/Vietnam/1203/2004 and is approved...

Added 4 years ago

A/H5N1 prepandemic influenza vaccine (whole virion, vero cell-derived, inactivated) [Vepacel®].

The influenza A subtype H5N1 virus is a likely causative agent for the next human influenza pandemic. Pandemic influenza vaccine...

Added 4 years ago